germanmile21
About
Breakthrough of N-(4-(3-isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-yl)-4-(4-methylpiperazin-1-yl)quinazolin-7-amine being a Book, Potent, and also Common Cyclin-Dependent Kinase Inhibitor against Haematological Malignancies.
Breakthrough of N-(4-(3-isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-yl)-4-(4-methylpiperazin-1-yl)quinazolin-7-amine being a Book, Potent, and also Common Cyclin-Dependent Kinase Inhibitor against Haematological Malignancies.